or Try an Advanced Search...

    Technical Analysis for OCX - OncoCyte Corporation

    Grade Last Price % Change Price Change
    D 3.00 -0.99% -0.03
    OCX closed down 0.99 percent on Friday, November 1, 2024, on 1.41 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical OCX trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 0.00%
    200 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction -0.99%
    NR7 Range Contraction -0.99%
    Older End-of-Day Signals for OCX ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support about 19 hours ago
    Down 3% about 19 hours ago
    Fell Below Lower Bollinger Band about 19 hours ago
    Lower Bollinger Band Support about 19 hours ago
    2x Volume Pace about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    OCX Chart by TradingView
    Basic chart:

    Profile

    OncoCyte Corporation focuses on developing diagnostic tests for the detection of breast, bladder, and lung cancers. The company was incorporated in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Oncology Stem Cell Breast Cancer Cell Biology Lung Cancer Diagnostic Tests

    Is OCX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 16 OncoCyte files for secondary stock offering
    Oct 16 Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
    Oct 8 Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
    Oct 4 OncoCyte Secures Funding Through Private Share Sale
    Aug 12 Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
    Aug 7 OncoCyte Q2 2024 Earnings Preview
    Aug 1 Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
    Jul 11 MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
    Jun 24 Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
    Jun 17 OncoCyte appoints CFO
    See more OCX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.34
    52 Week Low 2.08
    Average Volume 19,264
    200-Day Moving Average 2.97
    50-Day Moving Average 3.07
    20-Day Moving Average 3.08
    10-Day Moving Average 3.07
    Average True Range 0.15
    RSI (14) 44.75
    ADX 25.34
    +DI 14.55
    -DI 12.26
    Chandelier Exit (Long, 3 ATRs) 2.81
    Chandelier Exit (Short, 3 ATRs) 3.30
    Upper Bollinger Bands 3.17
    Lower Bollinger Band 2.99
    Percent B (%b) 0.05
    BandWidth 5.69
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0094
    Fundamentals Value
    Market Cap 24.78 Million
    Num Shares 8.26 Million
    EPS -3.37
    Price-to-Earnings (P/E) Ratio -0.89
    Price-to-Sales 16.72
    Price-to-Book 0.63
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.21
    Resistance 3 (R3) 3.20 3.12 3.17
    Resistance 2 (R2) 3.12 3.07 3.12 3.16
    Resistance 1 (R1) 3.06 3.03 3.02 3.07 3.15
    Pivot Point 2.98 2.98 2.96 2.99 2.98
    Support 1 (S1) 2.92 2.93 2.88 2.93 2.85
    Support 2 (S2) 2.84 2.89 2.85 2.84
    Support 3 (S3) 2.78 2.84 2.83
    Support 4 (S4) 2.79